Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc - Current Ratioverified

JAZZ

Price:

$255.97

Market Cap:

$16.08B

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to...[Read more]

Industry

Biotechnology

IPO Date

2007-06-01

Stock Exchange

NASDAQ

Ticker

JAZZ

The Current Ratio as of July 2026 (TTM) for Jazz Pharmaceuticals plc (JAZZ) is 2.04

According to Jazz Pharmaceuticals plc’s latest financial reports and current stock price. The company's current Current Ratio is 2.04. This represents a change of 13.86% compared to the average of 1.79 of the last 4 quarters.

Jazz Pharmaceuticals plc (JAZZ) Historical Current Ratio (quarterly & annually)

How has JAZZ Current Ratio performed in the past?

The mean historical Current Ratio of Jazz Pharmaceuticals plc over the last ten years is 3.32. The current 2.04 Current Ratio has changed 6.05% with respect to the historical average. Over the past ten years (40 quarters), JAZZ's Current Ratio was at its highest in in the June 2020 quarter at 5.62. The Current Ratio was at its lowest in in the June 2025 quarter at 1.62.

Quarterly (TTM)
Annual

Average

3.32

Median

3.26

Minimum

1.86

Maximum

4.47

Jazz Pharmaceuticals plc (JAZZ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Jazz Pharmaceuticals plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 99.37%

Maximum Annual Current Ratio = 4.47

Minimum Annual Increase = -58.32%

Minimum Annual Current Ratio = 1.86

Quarterly (TTM)
Annual
YearCurrent RatioChange
20251.86-58.32%
20244.4699.37%
20232.24-19.95%
20222.79-13.45%
20213.23-25.71%
20204.34-2.89%
20194.4725.22%
20183.578.43%
20173.2913.35%
20162.91-47.63%

Jazz Pharmaceuticals plc (JAZZ) Average Current Ratio

How has JAZZ Current Ratio performed in the past?

The current Current Ratio of Jazz Pharmaceuticals plc (JAZZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.85

5-year avg

2.91

10-year avg

3.32

Jazz Pharmaceuticals plc (JAZZ) Current Ratio vs. Peers

How is JAZZ’s Current Ratio compared to its peers?

Jazz Pharmaceuticals plc’s Current Ratio is less than Atrium Therapeutics, Inc. (13.04), less than Caris Life Sciences, Inc. (7.05), less than Merus N.V. (7.97), less than Madrigal Pharmaceuticals, Inc. (3.50), less than Abivax S.A. (8.75), less than Cytokinetics, Incorporated (4.21), less than Halozyme Therapeutics, Inc. (2.76), less than Rhythm Pharmaceuticals, Inc. (4.17), less than Nuvalent, Inc. (16.14), greater than Axsome Therapeutics, Inc. (1.39),

Build a custom stock screener for Jazz Pharmaceuticals plc (JAZZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jazz Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jazz Pharmaceuticals plc (JAZZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jazz Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Jazz Pharmaceuticals plc's Current Ratio?

How is the Current Ratio calculated for Jazz Pharmaceuticals plc (JAZZ)?

What is the highest Current Ratio for Jazz Pharmaceuticals plc (JAZZ)?

What is the 3-year average Current Ratio for Jazz Pharmaceuticals plc (JAZZ)?

What is the 5-year average Current Ratio for Jazz Pharmaceuticals plc (JAZZ)?

How does the current Current Ratio for Jazz Pharmaceuticals plc (JAZZ) compare to its historical average?